Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07083999

Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility

Prospective Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility Food Supplement Containing a Combination of MYO/DCI in a 3.6:1 Ratio, Antioxidants, Vitamins and Minerals

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Procare Health Iberia S.L. · Industry
Sex
Female
Age
32 Years – 38 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to evaluate whether supplementation with the Ovosicare® Fertility food supplement increases the possibility of becoming pregnant in women aged between 32 and 38 years who have been trying to become pregnant for at least 6 months before starting supplementation.

Detailed description

The duration of participation in the study for each patient will be a maximum of 18 months. This follow-up period may be shorter if a pregnancy occurs. The number of visits throughout the study will be a total of three. Please note that you will not have to undergo additional tests or attend any extraordinary visits due to participating in this study, since the procedures you will undergo are the same as those routinely carried out in clinical practice.

Conditions

Timeline

Start date
2025-02-13
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-07-24
Last updated
2025-07-24

Locations

27 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT07083999. Inclusion in this directory is not an endorsement.

Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility (NCT07083999) · Clinical Trials Directory